Author information from the last article
E-post: uxciak@ous-hf.no
Çiğdem Akalin Akkök er ph.d., spesialist i immunologi og transfusjonsmedisin og medisinsk ansvarlig overlege ved Nasjonalt referanselaboratorium for immunologiske utredninger ved Oslo universitetssykehus, Ullevål.
Articles by Çiğdem Akalin Akkök
Clinical Transfusion Handbook updated
- Tor Audun Hervig,
- Mirjana Grujic Arsenovic,
- Çiğdem Akalin Akkök,
- Barbora Jacobsen
18.06.2026:
The new edition of the handbook has been published on the metodebok.no portal. Transfusion medicine and blood transfusion are essential in patient care, including in the treatment of cancer, haematopoietic stem cell transplantation, solid organ transplantation and severe haemorrhage. Without...
New interest group for red blood cell disorders
- Nina Haagenrud Schultz,
- Anne Grete Bechensteen,
- Eirik Brekka Tjønnfjord,
- Çiğdem Akalin Akkök,
- Marte Holmboe Berg
20.02.2023:
Congenital red blood cell disorders are traditionally rare in Norway, and the focus on treatment and follow-up has been limited. A multidisciplinary approach is needed to ensure optimum, equal health care for patients with these disorders. Sickle cell disease and thalassemia are congenital...
Irradiation to prevent a fatal transfusion complication
- Sadaf Nabi Bhatti,
- Alice Gustavsen,
- Ingvild Sørvoll Hausberg,
- Marte Hvalryg,
- Anne Dorthea Bjerkenes Rø,
- Gunn Kristoffersen,
- Aurora Espinosa,
- Tine Torsvik Steinsvåg,
- Kristin Gjerde Hagen,
- Thomas Larsen Titze,
- Çiğdem Akalin Akkök
07.06.2021:
Cellular blood components should be irradiated as a preventive measure against transfusion-associated graft-versus-host disease in severely immunocompromised patients. The right blood component for the right patient, based on a correct and well-founded indication, is fundamental to sound transfusion...
A young woman with a transfusion-related pregnancy complication
- Alice Gustavsen,
- Ida Unhammer Njerve,
- Vasilis Sitras,
- Guttorm Haugen,
- Per Arne Tølløfsrud,
- Çiğdem Akalin Akkök
03.01.2020:
There will always be risks associated with transfusion, including the development of blood group antibodies. This case report emphasises the importance of considering whether transfusion is truly necessary. A young woman was diagnosed with iron deficiency anaemia with haemoglobin 7.0 g/dl (11.7–15.3...
RhD immunisation in pregnancy
- Çiğdem Akalin Akkök,
- Torbjørn Moe Eggebø,
- Torvid Kiserud,
- Hans Erik Heier
03.05.2016:
Postnatal prophylaxis with anti-RhD immunoglobulin has reduced the immunisation rate for RhD-negative women with an RhD-positive foetus by 80 %. Haemolytic disease of the foetus and newborn has become a rare cause of death. However, some foetuses do still develop severe anaemia as a result of RhD...
Paroxysmal nocturnal haemoglobinuria at Oslo University Hospital 2000–2010
- Lise Sofie Haug Nissen-Meyer,
- Geir E. Tjønnfjord,
- Elzbieta Golebiowska,
- Jens Kjeldsen-Kragh,
- Çiğdem Akalin Akkök
16.06.2015:
The rare disease paroxysmal nocturnal haemoglobinuria (PNH) has an estimated incidence of 1.3 cases per million population per year (1). Patients are classified as either classic PNH (without other bone marrow disease), secondary PNH (associated with bone marrow diseases such as aplastic anaemia and...
Hyperleukocytosis
- Çiğdem Akalin Akkök,
- Astrid Bergrem,
- Jon Magnus Tangen
05.08.2014:
A woman in her 40s was admitted acutely to the hospital due to poor general condition, acute onset nausea, vomiting, neck pain and headache. Upon admission, she had significant leukocytosis with a total leukocyte count of > 600 · 10 9 cells/L (3.5 – 10.0 · 10 9 cells/L). Further investigation with...
The Oslo Blood Bank, 22 July 2011
- Çiğdem Akalin Akkök
13.12.2011:
We were at work at the Blood Bank of Oslo University Hospital one grey summer afternoon when we thought we heard a loud thunderclap. But it wasn’t a thunderclap. «Yellow alert» was rapidly upgraded to «red alert». The Blood Bank of Oslo is the largest in Norway, and is supposed to stock a minimum of...